Nighttime blood pressure in elderly hypertensive patients Kazuyuki ShimadaKazuomi Kario Invited Commentary Pages: 495 - 496
Preventing renal disease progression: Is it the drug or the blood pressure reduction, or both? Matthew R. Weir Invited Commentary Pages: 497 - 499
The effect of lowering blood pressure on quality of life Christopher J. Bulpitt Clinical Trials Report Pages: 507 - 507
Hypertension and current issues in compliance and patient outcomes Teresa M. ZyczynskiKarin S. Coyne OriginalPaper Pages: 510 - 514
Observational studies of antihypertensive medication use and compliance: Is drug choice a factor in treatment adherence? Krista A. PayneSahra Esmonde-White OriginalPaper Pages: 515 - 524
Cost per millimeter of mercury lowering is a measure of economic value for antihypertensive agents Roland S. ChenPablo Lapuerta OriginalPaper Pages: 525 - 529
Methods and applications of quality-of-life measurement during antihypertensive therapy Marcia A. Testa OriginalPaper Pages: 530 - 537
The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis Theodore A. Kotchen Clinical Trials Report Pages: 541 - 542
Recent advances in the management of hypertension in the elderly F. John GennariAmelia S. Gennari OriginalPaper Pages: 543 - 550
Hypertension in patients presenting with stroke Ben J. PearsonPhilip M. W. BathJ. David Spence OriginalPaper Pages: 551 - 557